Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074

ClinicalTrials.gov ID: NCT01303744

Public ClinicalTrials.gov record NCT01303744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 6, 2026, 9:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and tolerability of ascending oral doses of CHF 5074 administered once per day for up to 12 weeks to patients with mild cognitive impairment.

Study identification

NCT ID: NCT01303744
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: CERESPIR; Industry
Enrollment: 96 participants

Conditions and interventions

Conditions

Alzheimer's Disease

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 79 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2011
Primary completion: Mar 31, 2012
Completion: Mar 31, 2012
Last update posted: Jan 10, 2016

2011 – 2012

United States locations

U.S. sites: 5
U.S. states: 3
U.S. cities: 5

Facility	City	State	ZIP	Site status
Comprehensive NeuroScience, Inc.	St. Petersburg	Florida	33716	—
Memory Enhancement Center of America, Inc.	Eatontown	New Jersey	07724	—
Memory Center of New Jersey, Inc.	Monroe Twp	New Jersey	08831	—
Memory Enhancement Center of NJ, Inc.	Toms River	New Jersey	08755	—
Senior Adults Specialty Research	Austin	Texas	78757	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01303744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 10, 2016 · Synced Sep 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01303744 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →